Trademark Search  /  AVONTEC

AVONTEC

○ Dead · Abandoned

U.S. federal trademark · Serial No. 76496366

Mark
AVONTEC
Status
Abandoned
Serial Number
76496366
Filing Date
March 10, 2003
Class(es)
Class 001, Class 005, Class 035, Class 041, Class 042

Owner

AVONTEC GmbH
16 · Gottingen, DE

Goods & Services

Chemical preparations, namely buffer, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, additives, polypeptides for scientific purposes; chemical preparations for the investigation and characterization of diseases, namely, of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for scientific purposes

Medicaments for the treatment of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; pharmaceutical and veterinary preparations for the control of the expression of genes relevant to said diseases; preparations for diagnosis and analysis of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for medical, analytical and diagnostic purposes

Arranging and conducting business conferences

Scientific and industrial research and consulting, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; identification of target structures for the development of medicaments, particularly polypeptides and nucleic acids; research and development of new technologies and pharmaceutical products for others, particularly for the control of the expression of genes relevant to diseases; product and technology research and development for others, namely, development of processes and products for scientific and industrial research, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; product development in the field of nucleic acids

Educational services, namely offering seminars, workshops and symposiums in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; arranging educational conferences, and providing facilities for educational conventions

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "AVONTEC" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.